{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:09:02Z","timestamp":1786979342844,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00689678","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T03:32:52Z","timestamp":1101699172000},"page":"73-82","source":"Crossref","is-referenced-by-count":126,"title":["The Royal Marsden Hospital pilot tamoxifen chemoprevention trial"],"prefix":"10.1007","volume":"31","author":[{"given":"T. J.","family":"Powles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E. R.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A.","family":"Tidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Treleavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"McKinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2964(76)90030-X","volume":"12","author":"VC Jordan","year":"1976","unstructured":"Jordan VC: Effect of tamoxifen (ICI 46, 474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur J Cancer 12: 419?424, 1976","journal-title":"Eur J Cancer"},{"key":"CR2","first-page":"4020","volume":"47","author":"MM Gottardis","year":"1987","unstructured":"Gottardis MM, Jordan VC: The antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 47: 4020?24, 1987","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/83.7.492","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, Lababidi MK, Langan-Fahey S: Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 83: 492?496, 1991","journal-title":"J Natl Cancer Inst"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.1.5844.13","volume":"1","author":"HWC Ward","year":"1973","unstructured":"Ward HWC: Antioestrogen therapy for breast cancer. A trial of tamoxifen at low dose levels. Br Med J 1: 13?15, 1973","journal-title":"Br Med J"},{"key":"CR5","first-page":"1","volume":"339","author":"EBCTCG","year":"1992","unstructured":"EBCTCG: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1?15, 71-85, 1992","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/83.18.1299","volume":"83","author":"LE Rutqvist","year":"1991","unstructured":"Rutqvist LE, Cedermark B, Glas Uet al.: Contralateral primary tumours in breast cancer patients in a randomised trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83: 1299?1306, 1991","journal-title":"J Natl Cancer Inst"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(86)90729-4","volume":"i","author":"J Cuzick","year":"1986","unstructured":"Cuzick J, Wang DK, Bulbrook RD: The prevention of breast cancer. Lancet i: 83?86, 1986","journal-title":"Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0140-6736(92)93161-F","volume":"340","author":"A Fugh-Berman","year":"1992","unstructured":"Fugh-Berman A, Epstein S: Tamoxifen: disease prevention or disease substitution? Lancet 340: 1143?1145, 1992","journal-title":"Lancet"},{"key":"CR9","first-page":"885","volume":"26","author":"SM Langan-Fahey","year":"1990","unstructured":"Langan-Fahey SM, Tormey DC, Jordan VC: Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. Eur J Cancer 26: 885?888, 1990","journal-title":"Eur J Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, De Mets DL: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852?856, 1992","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","volume":"82","author":"RR Love","year":"1992","unstructured":"Love RR, Newcomb PA, Wiebe D, Surawicz TS, Jordan VC, Carbone PP, De Mets DL: Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst 82: 1327?1338, 1992","journal-title":"J Natl Cancer Inst"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","volume":"303","author":"C McDonald","year":"1991","unstructured":"McDonald C, Stewart HJ: Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. Brit Med J 303: 435?437, 1991","journal-title":"Brit Med J"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/bjc.1989.235","volume":"60","author":"TJ Powles","year":"1989","unstructured":"Powles TJ, Hardy JR, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Dowsett M, McKinna JA, Nash AG, Sinnett HD, Tillyer CR, Treleaven JG: A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 60: 126?133, 1989","journal-title":"Br J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0277-5379(90)90116-B","volume":"26","author":"TJ Powles","year":"1990","unstructured":"Powles TJ, Tillyer CR, Jones AL, Ashley SE, Treleaven J, Davey JB, McKinna JA: Prevention of breast cancer with tamoxifen - an update on the Royal Marsden pilot programme. Eur J Cancer 26: 680?684, 1990","journal-title":"Eur J Cancer"},{"key":"CR15","unstructured":"Cuzick J: Protocol for the UKCCCR National Multicentre Tamoxifen Breast Cancer Prevention Trial. 1992"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/clinchem\/34.12.2456","volume":"34","author":"JS Cohn","year":"1988","unstructured":"Cohn JS, McNamara JR, Schaefer EJ: Lipoprotein and cholesterol concentrations in the plasma of human subjects as measured in the food and fasting status. Clin Chem 34: 2456?59, 1988","journal-title":"Clin Chem"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1469-0705.1991.01050359.x","volume":"1","author":"TH Bourne","year":"1992","unstructured":"Bourne TH: Transvaginal color Doppler in gynaecology. Ultrasound Obstet Gynecol 1: 359?373, 1992","journal-title":"Ultrasound Obstet Gynecol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","volume":"151","author":"WD Dupont","year":"1991","unstructured":"Dupont WD, Page DC: Menopausal estrogen replacement therapy and breast cancer. Arch Int Med 151: 67?73, 1991","journal-title":"Arch Int Med"},{"key":"CR19","first-page":"B60","volume":"34","author":"TL Bush","year":"1988","unstructured":"Bush TL, Fried LP, Barrett-Connor E: Cholesterol lipoproteins and coronary heart disease in women. Clin Chem 34: B60?70, 1988","journal-title":"Clin Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0021-9150(84)90064-9","volume":"53","author":"S Rossner","year":"1984","unstructured":"Rossner S, Wallgren A: Serum lipoproteins and protein after breast cancer surgery and effects of tamoxifen. Atherosclerosis 53: 339?346, 1984","journal-title":"Atherosclerosis"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphner","year":"1991","unstructured":"Saphner T, Tomey DC, Gray R: Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9: 286?294, 1991","journal-title":"J Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bjc.1992.350","volume":"66\/4","author":"AL Jones","year":"1992","unstructured":"Jones AL, Powles TJ, Treleaven J, Burman JF, Nicolson MC, Chung H-I, Ashley SE: Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women. Brit J Cancer 66\/4: 744?747, 1992","journal-title":"Brit J Cancer"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.1990.8.6.1019","volume":"8","author":"T Fornander","year":"1990","unstructured":"Fornander T, Rutqvist LE, Sjoberg HEet al.: Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncol 8: 1019?24, 1990","journal-title":"J Clin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"i","author":"T Fornander","year":"1989","unstructured":"Fornander T, Cedermark B, Mattson Aet al.: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet i: 117?120, 1989","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","volume":"343","author":"FE Leeuwen Van","year":"1994","unstructured":"Van Leeuwen FE, Benraadt J, Coebergh JWet al.: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343: 448?452, 1994","journal-title":"Lancet"},{"key":"CR26","first-page":"978","volume":"343","author":"TJ Powles","year":"1994","unstructured":"Powles TJ and Ashley S. Endometrial cancer during tamoxifen treatment. Lancet 343: 978, 1994","journal-title":"Lancet"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02109916","volume":"227","author":"I Gerhard","year":"1979","unstructured":"Gerhard I, Runnebaum B: Comparison between tamoxifen and clomiphene therapy in women with anovulation. Arch Gynaecol 227: 279?288, 1979","journal-title":"Arch Gynaecol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0140-6736(92)93162-G","volume":"340","author":"TJ Powles","year":"1992","unstructured":"Powles TJ: The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 340: 1145?1147, 1992","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-7435(91)90004-N","volume":"20","author":"JD Yagar","year":"1991","unstructured":"Yagar JD, Shi YE: Synthetic oestrogens and tamoxifen as promotors of hepatocarcinogenesis. Preventive Medicine 20: 27?37, 1991","journal-title":"Preventive Medicine"},{"key":"CR30","first-page":"1360","volume":"52","author":"X Han","year":"1992","unstructured":"Han X, Liehr JG: Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Research 52: 1360?1363, 1992","journal-title":"Cancer Research"},{"key":"CR31","first-page":"315","volume":"62","author":"MI Kaiser-Kupfer","year":"1978","unstructured":"Kaiser-Kupfer MI, Lippmann ME: Tamoxifen retinopathy. Cancer Treat Rep 62: 315?320, 1978","journal-title":"Cancer Treat Rep"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bjo.65.3.177","volume":"65","author":"C McKeown","year":"1981","unstructured":"McKeown C, Swartz M, Blom J, Maggiano JM: Tamoxifen retinopathy. Brit J Ophthalmol 65: 177?179, 1981","journal-title":"Brit J Ophthalmol"},{"issue":"12","key":"CR33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/0277-5379(89)90351-9","volume":"25","author":"S Longstaff","year":"1989","unstructured":"Longstaff S, Sigurdsson H, O'Keeffe Met al.: A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma. Eur J Cancer Clin Oncol 25 (12): 1805?1808, 1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","volume":"69","author":"N Pavlidis","year":"1992","unstructured":"Pavlidis N, Petris C, Briassoulis Eet al.: Clear evidence that long-term low-dose tamoxifen treatment can induce ocular toxicity. Cancer 69: 2961?2964, 1992","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689678\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T07:13:30Z","timestamp":1585984410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00689678"],"URL":"https:\/\/doi.org\/10.1007\/bf00689678","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}